Log In
Print this Print this

InflammaGen Shok-Pak

  Manage Alerts
Collapse Summary General Information
Company Leading BioSciences Inc.
DescriptionDrug delivery platform that administers an enzyme inhibitor into the stomach and lumen of intestine via a nasogastric tube
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationShock / trauma
Indication DetailsPrevent onset of shock and multiple organ failure
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today